Digital Detection of Sarcoma Fusion Genes
|SPEAKER:||Tony Ng MD, PhD, FRCPC, Consultant Pathologist BCCA and Vancouver General Hospital|
Jan 17, 2018
Sarcomas are a diverse group of malignancies that often require precise molecular diagnosis to guide therapy, usually through detection of fusion oncogene expression. These fusion oncogenes can occur throughout the genome and conjugate with novel partners, necessitating a technology that can robustly identify both known and unknown fusion types. Currently, most laboratories remain dependent on uni-plexed assays such as FISH, while next-generation sequencing approaches remain relatively cost-prohibitive. Join Tony Ng in this webinar as he discusses his experience in detecting the vast majority of sarcoma fusion gene variants with short turnaround time and low FFPE tissue requirements.